Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
Status:
Completed
Trial end date:
2021-09-13
Target enrollment:
Participant gender:
Summary
First, the investigators will determine whether Acceptance and Commitment Therapy in
combination with Contingency Management increases initial treatment response rates.
Second, for patients who do not respond to initial treatment, the investigators will examine
whether dopamine-targeted pharmacotherapy is an effective augmentation strategy.
Third, for patients who respond to initial treatment, the investigators will assess the
relative benefit of continued treatment with Acceptance and Commitment Therapy in combination
with Contingency Management, as compared to Drug Counseling in combination with Contingency
Management, to prevent relapse.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston